A new study led by researchers at Mount Sinai Health System has identified distinct biological signatures in patients with ...

Researchers at New York City-based Mount Sinai Health System have identified distinct biological markers in patients with mild Crohn’s disease, potentially paving the way for more personalized and ...

Treatment options for patients with moderately to severely active Crohn's disease have expanded in the past decade, with ...

A low-emulsifier-containing diet led to a threefold increased likelihood of improvement in symptoms of Crohn’s disease ...

In a major advance for patients with Crohn's disease, a new study led by researchers at Mount Sinai Health System found that ...

Chronic kidney disease doesn’t always cause constipation, but there are a number of reasons why it does for many people. Learn about potential causes and treatment.

Ustekinumab is more efficacious than vedolizumab or anti-TNFs as second- or third-line biologic therapy for perianal Crohn disease.

Fatty acids and other food compounds may change disease activity among individuals with inflammatory bowel diseases.